Where to Get Free Lenacapavir HIV Injection in Uganda (Full List)

Spread the love by sharing

Kampala, Uganda — May 6, 2026 — The Ministry of Health Uganda has officially rolled out a new long-acting HIV prevention injection known as lenacapavir, now available at selected health facilities across the country.

The breakthrough drug, which has shown nearly 100% effectiveness in clinical trials, is expected to significantly reduce new HIV infections, especially among high-risk groups.

This breakthrough could transform how millions protect themselves from HIV in Uganda.

What is Lenacapavir and How Does It Work?

Lenacapavir is a long-acting injectable drug used for HIV prevention. Unlike daily oral PrEP pills, this injection is administered once every six months, making it easier for individuals to stay protected.

According to health officials, a single dose provides protection for up to six months, offering a more convenient and discreet option for HIV prevention.

Where to Get the Lenacapavir Injection in Uganda

The Ministry has confirmed that the drug is available for free at the following health facilities:

Kampala

  • AIDS Information Centre Kampala Special Clinic
  • China-Uganda Friendship Hospital, Naguru
  • Kiruddu National Referral Hospital
  • Mulago National Referral Hospital (MARPI STI Clinic)
Free Lenacapavir HIV prevention injection in Uganda at Ministry of Health facility
Health officials during the rollout of Lenacapavir, a long-acting HIV prevention injection in Uganda

Other Regions

  • Gulu Regional Referral Hospital
  • Kitgum Hospital
  • Mbarara Regional Referral Hospital
  • Mbale Regional Referral Hospital
  • Kabale Regional Referral Hospital
  • Jinja Regional Referral Hospital
  • Mubende Regional Referral Hospital
  • Masaka Regional Referral Hospital
  • Entebbe Regional Referral Hospital
  • Soroti Regional Referral Hospital
  • Fort Portal Regional Referral Hospital
  • Arua Regional Referral Hospital
  • Yumbe Regional Referral Hospital

The drug was officially launched on April 17, 2026, at Lira Regional Referral Hospital by Health Minister Jane Ruth Aceng.

Dr. Jane Ruth Acheng, Minister of Health

During the launch, officials warned that Uganda risks reversing gains made in the fight against HIV if prevention efforts are not strengthened.

According to the Uganda AIDS Commission, thousands of new HIV infections are still recorded every year, particularly among:

Young women

Sex workers

Fishing communities

Other high-risk groups

The introduction of lenacapavir adds to existing prevention options such as

Oral PrEP pills

Dapivirine vaginal ring

Cabotegravir injections

Frequently Asked Questions

Is Lenacapavir free?

Yes, the government has confirmed that the available doses are free of charge.

How often is the injection given?

It is administered twice a year (every six months).

Also Read: Uganda Launches Injectable HIV Prevention Drug

Who should get it?

It is recommended for individuals at high risk of HIV infection. Visit a nearby facility for assessment.

With its long-lasting protection and high effectiveness, Lenacapavir could be a game-changer in Uganda’s HIV prevention efforts. Ugandans are encouraged to visit the listed health facilities and consult medical professionals for guidance.

written by @enock katamba

enock katamba
enock katamba
Enock Katamba – Journalist | Founder of Uncovered Ug (uncoveredug.com)

Enock Katamba is a Ugandan journalist and founder of Uncovered Uganda, a digital online news platform covering health, national news, entertainment, celebrity gossip, music, education, business, sports, and international news. He focuses on delivering accurate, timely, and reliable information to keep the public informed.

Coverage: Health | National | Education | Business | Sports | International | Entertainment | Celebrity Gossip | Music

Published 2,000+ articles on Uncovered Ug (uncoveredug.com)

Contact:
X (Twitter): @Enockkatamba6
Email: [email protected]
Phone: +256 758 287 080
Website: www.uncoveredug.com

Leave a Reply

Your email address will not be published. Required fields are marked *